Vanrafia (atrasentan) / Chinook Therap, AbbVie, Novartis  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vanrafia (atrasentan) / Novartis
NCT07319585: Managed Access Programs for EXV811, Atrasentan

Temporarily Not Available
N/A
NA
Atrasentan, EXV811
Novartis Pharmaceuticals
IgA Nephropathy
 
 
NCT06952426: A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

Recruiting
N/A
300
US
No intervention, Other treatment, Iptacopan, Atrasentan
Novartis Pharmaceuticals
Immunoglobulin A Nephropathy
06/25
06/25

Download Options